Telomerase activity as a prognostic marker in non small cell lung cancer Source: Annual Congress 2008 - Diagnosis and prognosis in thoracic oncology Year: 2008
Expression of Fhit protein in non-small cell lung cancer (NSCLC) and its correlation with Ki-67, a proliferative marker Source: Eur Respir J 2002; 20: Suppl. 38, 230s Year: 2002
The expression of Ki-67, a marker of proliferative activity, in resected nonsmall cell lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 478s Year: 2001
Her-2/neu expression in advanced non small cell lung carcinomas Source: Eur Respir J 2004; 24: Suppl. 48, 77s Year: 2004
The importance of Ki-67 proliferation index in small cell lung cancer Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020
Evaluation by immunohistochemistry of EGF-R expression before and after chemotherapy in non small cell lung cancer Source: Annual Congress 2005 - Chemotherapy and palliative care Year: 2005
Ki-67 in non-small cell lung cancer Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease Year: 2012
C-kit (CD 117): a new prognostic factor in small cell lung cancer (SCLC) Source: Eur Respir J 2001; 18: Suppl. 33, 478s Year: 2001
Prognostic significance of S-100 immmunostaining in non-small cell lung cancer (NSCLC) Source: Annual Congress 2004 - Prognostic factors Year: 2004
Prognostic significance of cytokeratin positive cells in bone marrow of non-small cell lung cancer patients Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008
Telomerase activity, micrometastasis and lynphonodal metastasis in resected non small cell lung cancer Source: Annual Congress 2008 - Diagnosis and prognosis in thoracic oncology Year: 2008
Telomerase expression in lung tumors Source: Eur Respir J 2003; 22: Suppl. 45, 198s Year: 2003
Prognostic significance of p53 and bcl-2 abnormalities in operable non-small cell lung cancer Source: Eur Respir J 2001; 17: 660-666 Year: 2001
KI67: Analysis of its expression and prognostic significance in a resected non small cell lung cancer population Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012
Immunohistochemical studies of COX-2, MMP-9, p53 and VEGF in non-small-cell lung cancer, specifically squamous cell carcinoma and adenocarcinoma Source: Eur Respir J 2006; 28: Suppl. 50, 387s Year: 2006
Correlation of P53 and CerbB-2 expression in the diagnostic biopsies and the corresponding resected tumors in non small cell lung caner Source: Eur Respir J 2004; 24: Suppl. 48, 43s Year: 2004
Expression of Her-2/neu and Bcl-2 in patients with non-small cell lung cancer Source: International Congress 2017 – Gene signatures in bronchial diseases Year: 2017
HER-2/neu oncoprotein expression in nonsmall cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 230s Year: 2002
The role of HER-2/neu, p53, Bcl-2 and Ki-67 in patients with lung cancer Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency Year: 2019
Expression of vascular endothelial growth factor (VEGF) and association with lymphangiogenesis in non small cell (NSCLC) and small cell lung carcinomas (SCLC) Source: Eur Respir J 2006; 28: Suppl. 50, 386s Year: 2006